Download FREE Report Sample
Download Free sampleKetorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.
Ketorolac Market contains market size and forecasts of Ketorolac in Global, including the following market information:
Global Ketorolac Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ketorolac market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ketorolac include Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical and Shandong New Era Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ketorolac companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ketorolac Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ketorolac Market Segment Percentages, by Type, 2021 (%)
Tablets
Injection
Eye Drops
Capsule
Global Ketorolac Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ketorolac Market Segment Percentages, by Application, 2021 (%)
Postoperative Pain
Acute Renal Colic
Biliary Colic
Toothache
And The Pain
Trigeminal Neuralgia
Cancer Visceral Pain
Seasonal Allergic Conjunctivitis
Other
Global Ketorolac Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ketorolac Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ketorolac revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ketorolac revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Femina Pharma
Fuisz Pharma
Allergan
Technical Chemicals & Products
Apotex Corporation
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Better Pharmaceutical
Yongxin Pharmaceutical Industry
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
